Stunning results from EVEREST trial at EAACI First ever prospective H2H of biologics in pts with Asthma and CRSwNP Sig and clinically relevant superiority for Dupilumab >Omalizumab on upper/lower airway outcomes Nuff said ...

EU-ADVANTAGE study Real life clinical remission more likely to be acheived with Dupilumab vs Omalizumab/Mepolizumab/Benralizumab in refractory severe asthma

Sporting the McLipworth tartan today Full disclosure I’m not Scottish but lived here for 39 years

Gorgeous views out to Jura tonight

Molly at Machrihanish

Well done to Bobby my fellow

Gorgeous light this evening silhouette of Islay and Jura

No cigar for Astegolimab in COPD 15% overall reduction in both phase 3 studies Need to see granular data for pts with Eos> 300/ul and FeNO>20 ppb in GOLD E subgroups roche.com/investors/upda…

Disconnect between effects of Dupilumab and Benralizumab on T2 biomakers and mannitol AHR annallergy.org/action/showPdf…

Effects of Dupilumab on small airways from VESTIGE RCT : Improved small airways function with Dupi due to direct effect on ASM (IL4/13 but not IL5 expression) and dissolution of mucus plugs jacionline.org/article/S0091-…

If you are a Fellow-in-Training who has published a print article in Annals of Allergy, Asthma & Immunology between 7/1/24-6/30/25, you are eligible for the FIT Awards! Deadline Aug. 15! You must be nominated - find out more here: loom.ly/r741zkw

Bronchodilator reversibility in severe asthma using spirometry and oscillometry ratios Here we desribe using R5-R20 and X5/AX as small airways outcomes with reversibility testing onlinelibrary.wiley.com/doi/10.1111/ce…

Peripheral resistance (R5-R20) and compliance (AX) but not FEV1 differentiates between Dupilumab and Tezepelumab in severe uncotrolled asthma onlinelibrary.wiley.com/doi/10.1111/al…